JUN 04, 2021 4:13 PM PDT

Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients

WRITTEN BY: Tara Fernandes

Scientists have developed miniaturized 3-dimensional bone marrow models that could help physicians to predict which patients would likely respond to therapies for blood platelet disorders.

Thrombocytopenic disorders are inherited conditions where the production of platelets—blood cells that circulate and bind when they sense blood vessel damage—are dysregulated. Patients with insufficient platelets are prone to internal hemorrhaging or uncontrolled bleeding after an injury. In these cases, patients are administered a drug called Eltrombopag.

The problem, says the study’s first author Christian Di Buduo, is that not all thrombocytopenia patients respond to Eltrombopag in the same way.

Di Buduo and their team created a miniature tissue-engineered model of the human bone marrow which consisted of a silk protein scaffold housing patient-derived bone marrow cells. "This device is a significant improvement over previous models, requiring only a very small sample of blood to recreate platelet production," Di Buduo said.

“Patients with the same apparent form of thrombocytopenia may respond differently to the treatment,” wrote the authors. “We describe a miniaturized bone marrow tissue model that provides a screening bioreactor for personalized, pre-treatment response prediction to eltrombopag for individual patients. Using silk fibroin, a 3D bone marrow niche was developed that reproduces platelet biogenesis.”

To validate their model, they obtained samples from a patient previously treated with Eltrombopag and showed that the number of platelets produced in the bone marrow cultures matched the patient’s response.

According to Di Buduo and colleagues, this development can help clinicians tailor platelet disorder treatments, making sure patients’ conditions are managed more effectively. In addition, they say that this model also represents a research tool that could pave the way for new and improved therapies to manage platelet disorders in the future.


Sources: GEN, eLife.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
AUG 03, 2022
Neuroscience
Children Use Creativity in Response to Novel Tasks
AUG 03, 2022
Children Use Creativity in Response to Novel Tasks
A study by a research group at the Max Planck Institute examined how children employ creativity when faced with novel ta ...
AUG 24, 2022
Health & Medicine
Vitamin D Supplements Could Alleviate Symptoms of Depression, Meta-Analysis Finds
AUG 24, 2022
Vitamin D Supplements Could Alleviate Symptoms of Depression, Meta-Analysis Finds
An extensive meta-analysis which was recently published in Critical Reviews in Food Science and Nutrition presents evide ...
AUG 29, 2022
Health & Medicine
US-Funded Research to be Open Access by 2026 Under New Federal Guidance
AUG 29, 2022
US-Funded Research to be Open Access by 2026 Under New Federal Guidance
If you have ever done research for school or work, or simply been curious about a scientific finding and wanted to read ...
SEP 05, 2022
Immunology
Long COVID Triggers Chronic Fatigue Syndrome
SEP 05, 2022
Long COVID Triggers Chronic Fatigue Syndrome
COVID-19 has been harmful to many aspects of human health. Recent research has shown, for example, that people are far l ...
SEP 07, 2022
Drug Discovery & Development
An Oral Insulin Pill is Getting Closer
SEP 07, 2022
An Oral Insulin Pill is Getting Closer
Diabetes is a chronic disease that requires constant monitoring. Patients have to check the level of sugar, or glucose i ...
SEP 20, 2022
Clinical & Molecular DX
The Health of Your Teeth Could Impact Your Heart: Here's How
SEP 20, 2022
The Health of Your Teeth Could Impact Your Heart: Here's How
A variety of past studies have shown that there is some connection between oral health and heart health. Gum disease is ...
Loading Comments...